Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity
Ophthalmic Research · 2023 · 66 (1) · 377-383
DOI: 10.1159/000528358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic Research, online erschienen am 28.11.2022. Verfasst von Jing Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Infant, Premature, Retinopathy of Prematurity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The aim of this study was to investigate the relevance of plasma levels of apelin and other risk factors in infants with retinopathy of prematurity (ROP).
Methods
This was a single-center cross-sectional study. Fifty preterm infants with ROP and 50 preterm infants without ROP were enrolled. The analysis included evaluation of gestational age (GA), birth weight (BW), and measurement of plasma concentrations of apelin, vascular endothelial growth factor (VEGF), erythropoietin (EPO), and insulin-like growth factor (IGF-1) using enzyme-linked immunosorbent assay.
Results
The mean BW and GA of babies with ROP were considerably lower than those without ROP (p < 0.001, p = 0.003, respectively). Plasma levels of VEGF, EPO, and IGF-1 were all lower in babies with ROP (all p < 0.001), while plasma apelin levels were greater (p < 0.001). We compared the sensitivity and selected the best cut-offs while keeping the specificity constant (80.0%). Among all the criteria, plasma apelin levels had the best sensitivity (72%), with the cut-off of 21.08 pg/mL. Multivariable logistic regression analyses showed that the plasma level of apelin was the only parameter associated with ROP (p = 0.02, OR = 16, 95% CI: 1.54–166.53). The area under the curve of the multivariable regression model that comprised GA, BW alone was 0.67, while that of the model that included apelin was 0.90.
Conclusions
Plasma apelin level demonstrated good sensitivity and specificity with regard to the association of ROP; the inclusion of apelin may be a promising factor to include in screening criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Ophthalmology, PLA Rocket Force Characteristic Medical Center, Beijing, China.
- Department of Pediatrics, PLA Rocket Force Characteristic Medical Center, Beijing, China.
- Department of Pediatrics, Peking University People's Hospital, Beijing, China.
Zitieren
APA
Feng, J., Liang, G., Gao, W., Li, X., Wei, L., Chang, H., Zhang, X., & Tao, Y. (2023). Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity. Ophthalmic Research, 66(1), 377-383. https://doi.org/10.1159/000528358
Vancouver
Feng J, Liang G, Gao W, Li X, Wei L, Chang H, et al. Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity. Ophthalmic Research. 2023;66(1):377-383. doi:10.1159/000528358
BibTeX
@article{Feng2023,
author = {Feng, Jing and Liang, Ge and Gao, Weiping and Li, Xiaoqin and Wei, Lin and Chang, Hongyu and Zhang, Xiaorui and Tao, Yong},
title = {Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity},
journal = {Ophthalmic Research},
year = {2023},
volume = {66},
number = {1},
pages = {377--383},
doi = {10.1159/000528358}
}
EUVIMED